Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Up 294.2% in June

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 134,800 shares, an increase of 294.2% from the May 31st total of 34,200 shares. Based on an average daily volume of 254,000 shares, the short-interest ratio is presently 0.5 days. Currently, 4.0% of the shares of the company are sold short.

Silo Pharma Stock Performance

Shares of Silo Pharma stock remained flat at $0.97 during trading hours on Friday. 52,056 shares of the company’s stock were exchanged, compared to its average volume of 186,804. The company’s fifty day simple moving average is $1.61 and its 200 day simple moving average is $1.63. Silo Pharma has a 1-year low of $0.91 and a 1-year high of $3.05.

Silo Pharma (NASDAQ:SILO) last issued its quarterly earnings results on Monday, May 13th. The company reported ($0.28) earnings per share (EPS) for the quarter. Silo Pharma had a negative return on equity of 51.75% and a negative net margin of 4,992.30%. The business had revenue of $0.02 million for the quarter.

Silo Pharma Company Profile

Silo Pharma. Inc, a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief.